Literature DB >> 9026832

[On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study].

E Chapadeiro1, L C Pitanga.   

Abstract

Surgical liver biopsies of patients of both sexes, between 18 and 72 years old, with the compensated hepatoesplenic form of schistosomiasis mansoni, previously treated with oxaminique (Mansil) were studied by histological and immunohistochemical methods. Although the search for parasites and/or granulomas was negative in all specimen studied, the portal fibrosis remained.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9026832     DOI: 10.1590/s0037-86821997000100010

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

Review 1.  Research and control of advanced schistosomiasis japonica in China.

Authors:  Wei Wu; Aicheng Feng; Yixin Huang
Journal:  Parasitol Res       Date:  2014-11-19       Impact factor: 2.289

2.  Praziquantel Targets M1 Macrophages and Ameliorates Splenomegaly in Chronic Schistosomiasis.

Authors:  Delong Kong; Chunlei Zhou; Hongfei Guo; Wei Wang; Jingfan Qiu; Xinjian Liu; Jinfeng Liu; Lijuan Wang; Yong Wang
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum infected mice.

Authors:  Bo-Lin Chen; Gui-Ying Zhang; Wei-Jian Yuan; Shi-Ping Wang; Yue-Ming Shen; Lu Yan; Huan Gu; Jia Li
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

4.  Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.

Authors:  Bo-Lin Chen; Jie Peng; Qing-Fu Li; Min Yang; Yuan Wang; Wei Chen
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.